0001127602-20-030120.txt : 20201130 0001127602-20-030120.hdr.sgml : 20201130 20201130165011 ACCESSION NUMBER: 0001127602-20-030120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201123 FILED AS OF DATE: 20201130 DATE AS OF CHANGE: 20201130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humphries William D. CENTRAL INDEX KEY: 0001674278 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 201358664 MAIL ADDRESS: STREET 1: C/O CLEARSIDE BIOMEDICAL, INC. STREET 2: 1220 OLD ALPHARETTA ROAD, SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bausch Health Companies Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc. DATE OF NAME CHANGE: 20100928 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-11-23 0000885590 Bausch Health Companies Inc. BHC 0001674278 Humphries William D. 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807 1 President, Ortho-Dermatologics Common Shares, No Par Value 2020-11-23 4 M 0 1483 14.38 A 236518 D Common Shares, No Par Value 2020-11-24 4 M 0 21658 14.38 A 258176 D Common Shares, No Par Value 2020-11-23 4 S 0 1483 19.6328 D 235035 D Common Shares, No Par Value 2020-11-24 4 S 0 21658 19.6323 D 235035 D Common Shares, No Par Value 2020-11-27 4 M 0 13663 14.38 A 248698 D Common Shares, No Par Value 2020-11-27 4 S 0 13663 19.6302 D 235035 D Non-qualified Stock Options (right To Purchase) 14.38 2020-11-23 4 M 0 1483 0 D 2027-03-01 Common Shares, No Par Value 1483 149376 D Non-qualified Stock Options (right To Purchase) 14.38 2020-11-24 4 M 0 21658 0 D 2027-03-01 Common Shares, No Par Value 21658 127718 D Non-qualified Stock Options (right To Purchase) 14.38 2020-11-27 4 M 0 13663 0 D 2027-03-01 Common Shares, No Par Value 13663 114055 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.64 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.66 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.635 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote. The options vest in equal installments on each of the first three anniversaries of the date of grant. /s/ Kirsten O'Donnell, attorney-in-fact for William D. Humphries 2020-11-30